In a large cohort of individuals diagnosed with neurodevelopmental disorders, the prevalence of de novo GRIN2B variants that are likely pathogenic was 0.2% (Platzer et al., 2017). The gene discussed is GRIN2B; the disease is neurodevelopmental disorder.